Factors Related to the Glucose-Lowering Efficacy of Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Meta-Analysis Focusing on Ethnicity and Study Regions Kayo FujitaMasayuki KanekoMamoru Narukawa Systematic Review 16 November 2016 Pages: 219 - 232
Cost-Effectiveness Comparison Between the Response-Guided Therapies and Monotherapies of Nucleos(t)ide Analogues for Chronic Hepatitis B Patients in China Keng LaiChi ZhangYi Yang Original Research Article 07 December 2016 Pages: 233 - 247
Pharmacokinetic Profile and Tolerability of Liposomal Bupivacaine Following a Repeated Dose via Local Subcutaneous Infiltration in Healthy Volunteers David RiceJustin W. HeilLukasz Biernat Original Research Article 25 January 2017 Pages: 249 - 257
Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme Robert KimutaiAhmed M. MusaMonique Wasunna Original Research Article Open access 09 January 2017 Pages: 259 - 272
Quantifying the Exposure of Tapentadol Extended Release in Japanese Patients with Cancer Pain and Bridging Tapentadol Pharmacokinetics Across Populations Using a Modeling Approach Liping ZhangXiaoyu YanPartha Nandy Original Research Article 17 November 2016 Pages: 273 - 283
Cost-Effectiveness Analysis of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation in Taiwan Chieh-Yu LiuHui-Chun Chen Original Research Article 17 December 2016 Pages: 285 - 293
A Randomized, Single-Blind Trial of Clobetasol Propionate 0.05% Cream Under Silicone Dressing Occlusion Versus Intra-Lesional Triamcinolone for Treatment of Keloid Norazirah Md NorRasimah IsmailFarah Hani Imran Short Communication 25 November 2016 Pages: 295 - 301
Evaluation of the Pharmacokinetic Interaction between Venetoclax, a Selective BCL-2 Inhibitor, and Warfarin in Healthy Volunteers Ahmed Hamed SalemBeibei HuShekman L. Wong Short Communication 02 December 2016 Pages: 303 - 309
Effect of Multiple Oral Doses of the Potent CYP3A4 Inhibitor Clarithromycin on the Pharmacokinetics of a Single Oral Dose of Vonoprazan: A Phase I, Open-Label, Sequential Design Study Helen JenkinsRichard JenkinsAlain Patat Short Communication 07 December 2016 Pages: 311 - 316